Pulmonx Corporation Operating Margin 2019-2024 | LUNG
Current and historical operating margin for Pulmonx Corporation (LUNG) over the last 10 years. The current operating profit margin for Pulmonx Corporation as of September 30, 2024 is -67.31%.
| Pulmonx Corporation Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-09-30 | $0.08B | $-0.06B | -74.68% |
| 2024-06-30 | $0.08B | $-0.06B | -77.92% |
| 2024-03-31 | $0.07B | $-0.06B | -82.19% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -95.38% |
| 2023-06-30 | $0.06B | $-0.06B | -100.00% |
| 2023-03-31 | $0.06B | $-0.06B | -101.72% |
| 2022-12-31 | $0.05B | $-0.06B | -109.26% |
| 2022-09-30 | $0.05B | $-0.06B | -105.66% |
| 2022-06-30 | $0.05B | $-0.05B | -100.00% |
| 2022-03-31 | $0.05B | $-0.05B | -102.00% |
| 2021-12-31 | $0.05B | $-0.05B | -97.92% |
| 2021-09-30 | $0.04B | $-0.04B | -100.00% |
| 2021-06-30 | $0.04B | $-0.04B | -92.86% |
| 2021-03-31 | $0.03B | $-0.04B | -111.76% |
| 2020-12-31 | $0.03B | $-0.03B | -94.12% |
| 2020-06-30 | $0.02B | $-0.02B | -100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||